Results 21 to 30 of about 14,017 (290)

The case for medicinal cannabis [PDF]

Irish Journal of Medical Science (1971 -), 2018
no abstract ...
Jane, O'Doherty, Ray, O'Connor
openaire   +4 more sources

Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer’s disease symptoms: a case report

Journal of Medical Case Reports, 2022
Background Cannabinoid-based therapy has been shown to be promising and is emerging as crucial for the treatment of cognitive deficits, mental illnesses, and many diseases considered incurable. There is a need to find an appropriate therapy for Alzheimer’
Ana Carolina Ruver-Martins, Maíra Assunção Bicca, Fabiano Soares de Araujo, Beatriz Helena Lameiro de Noronha Sales Maia, Fabrício Alano Pamplona, Elton Gomes da Silva, Francisney Pinto Nascimento   +6 more
doaj   +1 more source

Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial

Frontiers in Psychiatry, 2021
Background: Anxiety and depressive disorders are highly prevalent. Patients are increasingly using medicinal cannabis products to treat these disorders, but little is known about the effects of medicinal cannabis use on symptoms of anxiety and depression.
Erin L. Martin, Justin C. Strickland, Nicolas J. Schlienz, Nicolas J. Schlienz, Joel Munson, Heather Jackson, Marcel O. Bonn-Miller, Ryan Vandrey   +7 more
doaj   +1 more source

‘A glimmer of hope’: perceptions, barriers, and drivers for medicinal cannabis use amongst Australian and New Zealand people with endometriosis – a qualitative study

Reproduction and Fertility, 2023
Previous quantitative research has shown that cannabis use, mostly illicit, is used for symptom management amongst those with endometriosis living in Australia or New Zealand, but the drivers and barriers for use of legal, medicinal cannabis in this ...
Justin Sinclair, Jason Abbott, Antonina Mikocka-Walus, Cecilia Ng, Jerome Sarris, Subhadra Evans, Mike Armour   +6 more
doaj   +1 more source

Implementation of medicinal cannabis in Australia: innovation or upheaval? Perspectives from physicians as key informants, a qualitative analysis

BMJ Open, 2021
Objective We sought to explore physician perspectives on the prescribing of cannabinoids to patients to gain a deeper understanding of the issues faced by prescriber and public health advisors in the rollout of medicinal cannabis.Design A thematic ...
Christine Mary Hallinan, Jane Maree Gunn, Yvonne Ann Bonomo   +2 more
doaj   +1 more source

Views on and experiences with medicinal cannabis among Canadian veterans who live with pain: A qualitative study

Canadian Journal of Pain, 2023
Background During fiscal year 2021–2022, Veterans Affairs Canada (VAC) reimbursed 18,388 veterans for medicinal cannabis at a cost of $153 million. Yet, it is not known whether the reimbursement program is producing a net benefit for veterans.Aims This ...
David P. Storey, Natalie R. Keeler-Villa, Nick Harris, Jennifer Anthonypillai, Gregory K. Tippin, Vikas Parihar, Joshua A. Rash   +6 more
doaj   +1 more source

Medicinal Cannabis and Central Nervous System Disorders

Frontiers in Pharmacology, 2022
Cannabinoids, including those found in cannabis, have shown promise as potential therapeutics for numerous health issues, including pathological pain and diseases that produce an impact on neurological processing and function.
Yuma T. Ortiz, Lance R. McMahon, Jenny L. Wilkerson   +2 more
doaj   +1 more source

Cannabis Medicinal: Investigaciones colaborativas de las ciencias sociales [PDF]

, 2023
Este artículo presenta la labor realizada por la Comisión de Ciencias Sociales de la Red de Cannabis de Uso Medicinal e Industrial del CONICET (RACME), integrada por investigadorxs, representantes de ONG, profesionales y docentes.
Aguirre, Roxana, Calzolary, Gabriela, Romero, Lucia Ana, Pimpinella, Sabrina, Díaz, María Cecilia, Pedrana, María Soledad, Corbelle, Florencia   +6 more
core   +1 more source

Brief interventions for cannabis use in emerging adults: protocol for a systematic review, meta-analysis, and evidence map

Systematic Reviews, 2018
Background Rates of cannabis use are highest during emerging adulthood (age 18–25), with the prevalence of near daily and daily increasing among this age group.
Jillian Halladay, Tashia Petker, Allan Fein, Catharine Munn, James MacKillop   +4 more
doaj   +1 more source

Using Social Media Data to Investigate Public Perceptions of Cannabis as a Medicine: Narrative Review

Journal of Medical Internet Research, 2023
BackgroundThe use and acceptance of medicinal cannabis is on the rise across the globe. To support the interests of public health, evidence relating to its use, effects, and safety is required to match this community demand.
Sedigh Khademi, Christine Mary Hallinan, Mike Conway, Yvonne Bonomo   +3 more
doaj   +1 more source